Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist not approved by the MHRA or EMA
Preparation for surgery sometimes requires temporarily stopping
Tirzepatide does not increase lactic acidosis risk
Berberine should be avoided or used only under medical supervision in the following groups: Pregnant or breastfeeding women Children and adolescents Individuals with liver or kidney impairment Those taking multiple prescription medicines, particularly narrow therapeutic index drugs People with a history of hypoglycaemia or taking glucose-lowering medicines Anyone taking warfarin, digoxin, ciclosporin, or tacrolimus If you are unsure whether berberine is appropriate for you, your GP or a registered pharmacist is the most appropriate first point of contact
US$ 27.75
US$ 21.51
US$ 24.34
US$ 24.46
US$ 22.19
US$ 28.52
US$ 26.48
US$ 22.22
US$ 28.47
